• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Research on Pathomechanism and a novel treatment of HTLV-I-associated myelopathy (HAM)

Research Project

Project/Area Number 09470155
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Neurology
Research InstitutionKagoshima University

Principal Investigator

OSAME Mitsuhiro  Faculty of Medicine, Kagoshima University, Professor, 医学部, 教授 (10041435)

Co-Investigator(Kenkyū-buntansha) USUKU Koichiro  Faculty of Medicine, Kagoshima University, Associate Professor, 医学部, 助教授 (30281223)
IZUMO Shuji  Faculty of Medicine, Kagoshima University, Professor, 医学部, 教授 (30143811)
NAKAGAWA Masanori  University Hospital, Kagoshima University, Assistant Professor, 医学部・附属病院, 講師 (50198040)
ARIMURA Kimiyoshi  Faculty of Medicine, Kagoshima University, Associate Professor, 医学部, 助教授 (20159510)
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥12,900,000 (Direct Cost: ¥12,900,000)
Fiscal Year 1998: ¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 1997: ¥9,600,000 (Direct Cost: ¥9,600,000)
KeywordsHAM / HTLV-I / proviral load / neopterin / viral antibody / infected cell number / HTLV-Iプロウイルス量 / PCR定量 / HTLV-Iキャリア
Research Abstract

HTLV-I proviral load in peripheral blood mononuclear cells (PBMC) from a large number of HAM/TSP patients and asymptomatic HTLV-I carriers were measured to explored the importance of HTLV-I proviral load to the pathomechanism of HAM.The proviral load was measured by an accurate and reproducible quantitative PCR method using a dual-labeled fluorogenic probe (ABI PRISM 7700 Sequence Detection System). The mean +1- standard error of mean (s.e.m.) HTLV-I proviral copy number per 1 x 10(4) PBMC was 798 1- 51 (median 544) in 202 HAM/TSP patients ; 120 +1- 17 (median 34) in 200 non HAM-related (general) asymptomatic HTLV-I carriers (RC) ; and 496 +/- 82 (median 321) in 43 asymptomatic HTLV-I carriers genetically related to HAM/TSP patients (FA). The prevalence of HAM/TSP rises exponentially with log (proviral load) once the proviral load exceeds 1% PBMC.The HTLV-I proviral load of female patients with HAM/TSP was significantly higher than that of male patients, however there was no significan … More t difference in proviral load between sexes in RC.There was a significant correlation between the proviral load and the concentration of neopterin in CSF of HAM/TSP patients. These results indicate that the HTLV-I proviral load in PBMC may be related to the inflammatory process in the spinal cord lesion. The increased proviral load in FA suggests the existence of genetic factors contributing to the replication of HTLV-I in vivo. Furthermore in order to elucidate the localization of HTLV-I proviral DNA directly, we performed double staining using immunohistochemistry and PCR in situ hybridization (PCR-ISH). Fresh frozen sections of the spinal cord from four HAM patients taken at autopsy were first immunostained with antibodies to pan T cells (UCHL-1), macrophages (KP-1) and helper/inducer T cells (OPD4). Then PCR-ISH was carried out with specific primers and probe for the HTLV-I pX region. UCHL- 1-positive cells were noted around perivascular areas and, to some extent, in the parenchyma. Of the UCHL-1-positive cells, 9.4% (case 1), 9.6% (case 2), 1.1% (case 3) and 6.7% (case 4) became positive in HTLV-I PCR-ISH.UCHL-1-negative cells were HTLV-I PCR-ISH negative and almost all KP-l-positive cells were HTLV-I negative. HTLV-I was localized to OPD4-positive cells in examined lesions of cases 2 and 4. These data are a direct demonstration of HTLV-1 proviral DNA localizing to infiltrated T cells in HAM/TSP spinal cord lesions. Less

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Nagai M.et al.: "Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP." J Neurovirol. 4・6. 586-593 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kasai,T.et al.: "A rat model of human T lymphocyte virus type I(HTLV-I) infection: in situ detection of HTLV-I provirus DNA in microgilia/macrophages in affected spinal cords of rats with HTLV-I-induced chronic progressive myeloneuropathy." Acta Neuropathol. 97・2. 107-112 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Eiraku,N.et al.: "Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals." J Immunol. 161・12. 6674-6680 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kawahigashi,N.et al.: "Predominant expression of Fas ligand mRNA in CD8+ T lymphocytes in patients with HTLV-1 associated myelopathy." J Neuroimmunol. 90・2. 199-206 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Matsuoka,E.et al: "Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy/tropical spastic paraparesis: double staining of immunohistochemistry and polymerase chain reaction in situ hybridization." Acta Neuropathol. 96・4. 340-346 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Umehara,F.et al.: "Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy." J Neuropathol Exp Neurol. 57・9. 839-849 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Nagai M.et al.: "Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers : high proviral load strongly predisposes to HAM/TSP." J Neurovirol. 4 (6). 586-593 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kasai, T.et al.: "A rat model of human T lymphocyte virus type I (HTLV-I) infection : in situ detection of HTLV-I provirus DNA in microglia/macrophages in affected spinal cords of rats with HTLV-I-induced chronic progressive myeloneuropathy." Acta Neuropathol. 97 (2). 107-112 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Eiraku, N.et al.: "Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals." J Immunol. 161 (12). 6674-6680 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kawahigashi, N.et al.: "Predominant expression of Fas ligand mRNA in CD8+ T lymphocytes in patients with HTLV-1 associated myelopathy." J Neuroimmunol. 90 (2). 199-206 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Matsuoka, E.et al.: "Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy/tropical spastic paraparesis : double staining of immunohistochemistry and polymerase chain reaction in situ hybridization." Acta Neuropathol. 96 (4). 340-346 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Umehara, F.et al.: "Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy." J Neuropathol Exp Neurol. 57 (9). 839-849 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Nagai,M.,et al.: "Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLVーI carriers:High proviral load strongly predispose to HAM/TSP." J.NeuroVirol.4. 586-593 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Matsuoka,E.et al.: "Perivascular T-cells are infected with HTLV-I in the spinal cord lesions with HAM/TSP:Double staining of immunohistochemistry and PCR in situ hybridization." Acta Neuropathol. 96. 340-346 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Yamano Y., et al.: "Alteration of cytokine levels by fosfomycin and prednisolone in spontaneous proliferation of cultured lymphocytes from patients with HTLV-I-associated myelopathy (HAM/TSP)" J Neurol Sci.151. 163-167 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Yamano Y., et al.: "Preferential recognition of synthetic peptides from HTLV-I gp21 envelbpe protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis)." J Neuroimmunol.76. 50-60 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Achiron A.,et al.: "Detection of HTLV type I provirus by in situ polymerase chain reaction in mouthwash mononuclear cells of HAM/TSP patients and HTLV type I carriers." AIDS Res Hum Retroviruses. 13. 1067-1070 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Machigashira K.,et al.: "In vitro virus propagation and high cellular responsiveness to the infected cells in patients with HTLV-I-associated myelopathy (HAM/TSP)." J Neurol Sci.49. 141-145 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Osame M,et al.: "Recent studies on the epidemiology,clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV." J Neurovirol.3 Sup 1. S50-S51 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Inoue A,et al.: "Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy." J Neuroimmunol.75. 141-146 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi